MIRA PHARMACEUTICALS, INC. Net Income Loss

Quick Answer

MIRA PHARMACEUTICALS, INC. reported Net Income Loss of -$10.44 million for the year ending 2025.

  • MIRA PHARMACEUTICALS, INC. showed a decrease of -33.0% in Net Income Loss from 2024 to 2025.
  • This data is from MIRA PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), MIRA PHARMACEUTICALS, INC.'s Net Income Loss has declined by 47.9%.
  • Historical annual values: Fiscal year 2025: -$10.44 million | Fiscal year 2024: -$7.85 million | Fiscal year 2023: -$11.98 million | Fiscal year 2022: -$7.06 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: